Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Laurini

Showing results (31-40 of 118) with videos related to

Pageof 12
Sort By:
Chemical Communications (Cambridge, England)|October 10, 2017
Effect of buffer at nanoscale molecular recognition interfaces - electrostatic binding of biological polyanionsAna C Rodrigo, Erik Laurini, Vânia M P Vieira, et al.
Pharmaceutics|April 27, 2024
Molecular Ballet: Investigating the Complex Interaction between Self-Assembling Dendrimers and Human Serum Albumin via Computational and Experimental MethodsGabriele Cavalieri, Domenico Marson, Nicoletta Giurgevich, et al.
Bioorganic & Medicinal Chemistry Letters|February 4, 2014
Synthesis and receptor binding studies of some new arylcarboxamide derivatives as sigma-1 ligandsDaniele Zampieri, Erik Laurini, Luciano Vio, et al.
European Journal of Medicinal Chemistry|July 5, 2014
Identification, pharmacological evaluation and binding mode analysis of novel chromene and chromane based σ1 receptor ligandsErik Laurini, Dipak Harel, Domenico Marson, et al.
Chemical Communications (Cambridge, England)|May 31, 2017
Morphological control of self-assembled multivalent (SAMul) heparin binding in highly competitive mediaAna C Rodrigo, Stephen M Bromfield, Erik Laurini, et al.
Chemical Biology & Drug Design|February 13, 2013
Identification of peptides with ELAV-like mRNA-stabilizing effect: an integrated in vitro/in silico approachMarialaura Amadio, Alessia Pascale, Stefano Govoni, et al.
Pharmaceuticals (Basel, Switzerland)|November 18, 2020
Novel 1-Amidino-4-Phenylpiperazines as Potent Agonists at Human TAAR1 Receptor: Rational Design, Synthesis, Biological Evaluation and Molecular Docking StudiesValeria Francesconi, Elena Cichero, Evgeny V Kanov, et al.
Bioorganic & Medicinal Chemistry|January 13, 2018
9-Aminoacridine-based agents impair the bovine viral diarrhea virus (BVDV) replication targeting the RNA-dependent RNA polymerase (RdRp)Roberta Loddo, Valeria Francesconi, Erik Laurini, et al.
Molecular Pharmaceutics|January 3, 2012
Efficient delivery of sticky siRNA and potent gene silencing in a prostate cancer model using a generation 5 triethanolamine-core PAMAM dendrimerXiaoxuan Liu, Cheng Liu, Erik Laurini, et al.
European Journal of Medicinal Chemistry|December 22, 2014
Improving selectivity preserving affinity: new piperidine-4-carboxamide derivatives as effective sigma-1-ligandsDaniele Zampieri, Erik Laurini, Luciano Vio, et al.
Pageof 12

Showing results (31-40 of 118) with videos related to

Sort By:
Pageof 12
Chemical Communications (Cambridge, England)|October 10, 2017
Effect of buffer at nanoscale molecular recognition interfaces - electrostatic binding of biological polyanionsAna C Rodrigo, Erik Laurini, Vânia M P Vieira, et al.
Pharmaceutics|April 27, 2024
Molecular Ballet: Investigating the Complex Interaction between Self-Assembling Dendrimers and Human Serum Albumin via Computational and Experimental MethodsGabriele Cavalieri, Domenico Marson, Nicoletta Giurgevich, et al.
Bioorganic & Medicinal Chemistry Letters|February 4, 2014
Synthesis and receptor binding studies of some new arylcarboxamide derivatives as sigma-1 ligandsDaniele Zampieri, Erik Laurini, Luciano Vio, et al.
European Journal of Medicinal Chemistry|July 5, 2014
Identification, pharmacological evaluation and binding mode analysis of novel chromene and chromane based σ1 receptor ligandsErik Laurini, Dipak Harel, Domenico Marson, et al.
Chemical Communications (Cambridge, England)|May 31, 2017
Morphological control of self-assembled multivalent (SAMul) heparin binding in highly competitive mediaAna C Rodrigo, Stephen M Bromfield, Erik Laurini, et al.
Chemical Biology & Drug Design|February 13, 2013
Identification of peptides with ELAV-like mRNA-stabilizing effect: an integrated in vitro/in silico approachMarialaura Amadio, Alessia Pascale, Stefano Govoni, et al.
Pharmaceuticals (Basel, Switzerland)|November 18, 2020
Novel 1-Amidino-4-Phenylpiperazines as Potent Agonists at Human TAAR1 Receptor: Rational Design, Synthesis, Biological Evaluation and Molecular Docking StudiesValeria Francesconi, Elena Cichero, Evgeny V Kanov, et al.
Bioorganic & Medicinal Chemistry|January 13, 2018
9-Aminoacridine-based agents impair the bovine viral diarrhea virus (BVDV) replication targeting the RNA-dependent RNA polymerase (RdRp)Roberta Loddo, Valeria Francesconi, Erik Laurini, et al.
Molecular Pharmaceutics|January 3, 2012
Efficient delivery of sticky siRNA and potent gene silencing in a prostate cancer model using a generation 5 triethanolamine-core PAMAM dendrimerXiaoxuan Liu, Cheng Liu, Erik Laurini, et al.
European Journal of Medicinal Chemistry|December 22, 2014
Improving selectivity preserving affinity: new piperidine-4-carboxamide derivatives as effective sigma-1-ligandsDaniele Zampieri, Erik Laurini, Luciano Vio, et al.
Pageof 12